BCR-mediated decrease of CXCR4 and CD62L in CLL - Response

Cancer Research

Volumn 70, Issue 12, 2010, Pages 5195-

  Vlad, Amalia ^a   Ajchenbaum Cymbalista, Florence ^a   Varin Blank, Nadine ^a   Ledoux, Dominique ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; IMMUNOGLOBULIN M ANTIBODY; L SELECTIN; PROTEIN KINASE SYK; PROTEIN KINASE SYK INHIBITOR; R 788; UNCLASSIFIED DRUG;

APOPTOSIS; BONE MARROW CELL; CELL MIGRATION; CELL SURVIVAL; CHEMOTAXIS; CHRONIC LYMPHATIC LEUKEMIA; COMPETITIVE INHIBITION; HUMAN; LETTER; LEUKEMIA CELL; LYMPH NODE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; STROMA CELL;

EID: 77953736223     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-1117     Document Type: Letter

References (5)

1. Deglesne PA, Chevallier N, Letestu R, et al. Survival response to B-cell receptor ligation is restricted to progressive chronic lymphocytic leukemia cells irrespective of Zap70 expression. Cancer Res 2006; 66:7158-66.
2. Zupo S, Massara R, Dono M, et al. Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD. Blood 2000;95:1199-206.
3. Petlickovski A, Laurenti L, Li X, et al. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells. Blood 2005;105:4820-7.
4. Stamatopoulos B, Meuleman N, De Bruyn C, Delforge A, Bron D, Lagneaux L. The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces apoptosis, downregulates the CXCR4 chemokine receptor and impairs migration of chronic lymphocytic leukemia cells. Haematologica. Epub 2010 Feb 9.
5. Herishanu Y, Vire B, Liu D, et al. The role of the microenvironment for CLL proliferation and survival: gene expression profiling of leukemic cells derived from blood, bone marrow and lymph nodes reveals the B-cell receptor and NF {kappa}B as dominant signaling pathways. Blood 2008;112:356.